| Abby Noel Oresman, | |
|
53 Tallman Ave, Portsmouth, RI 02871-4322 | |
| (401) 499-4636 | |
| Not Available |
| Full Name | Abby Noel Oresman |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 53 Tallman Ave, Portsmouth, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538944608 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 14202026 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Abby Noel Oresman, 53 Tallman Ave, Portsmouth, RI 02871-4322 Ph: (401) 499-4636 | Abby Noel Oresman, 53 Tallman Ave, Portsmouth, RI 02871-4322 Ph: (401) 499-4636 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that it has completed enrolling patients in all four previously announced prospective, open-label clinical studies investigating Soliris® (eculizumab) as a potential treatment for patients with atypical Hemolytic Uremic Syndrome (aHUS) being conducted in North America and multiple European countries.
A research review carried out by the HRB Centre for Primary Care Research, based in the Royal College of Surgeons in Ireland (RCSI) and published in this month's edition of the British Medical Journal (BMJ) has focused on how we can improve care and outcomes for patients with multimorbidity (co-existence of two or more long-terms health conditions in an individual).
An unexplored kinase in heart muscle cells may be a good target to treat heart failure, a disease that is only incrementally delayed by existing therapies.
A report issued Tuesday by the American Academy of Family Physicians urges the concept of medical homes as a solution to the looming primary care shortage, but argues that such practices should still be led by doctors.
People suffering from chronic, debilitating pain caused by nerve damage or disease report better pain relief at lower doses of a combined drug treatment than from either drug administered individually, a new Queen's study funded by the Canadian Institutes of Health Research (CIHR) shows.
› Verified 4 days ago
Elena Post, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2974 E Main Rd, Portsmouth, RI 02871 Phone: 401-293-5790 | |
Dahlia Siff Kalvinek, MS SSS-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2974 E Main Rd, Portsmouth, RI 02871 Phone: 401-293-5790 | |
Erin Elizabeth Aleicho, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 48 Canonchet Dr, Portsmouth, RI 02871 Phone: 401-662-0090 | |
Mrs. Debra M Smith, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 38 W Passage Dr, Portsmouth, RI 02871 Phone: 401-683-0334 | |
Ms. Elizabeth Hird Morley, M.S.,CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 114 Col Christopher Greene Rd, Portsmouth, RI 02871 Phone: 401-849-6745 | |
Mrs. Stephanie Elisabeth Conrad Kelley, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11 King Charles Dr Ste A2, Portsmouth, RI 02871 Phone: 401-267-8757 Fax: 401-221-4242 |